Wenzel S E, Westcott J Y, Larsen G L
Department of Medicine, National Jewish Center for Immunology and Respiratory Medicine, Denver, Colo. 80206.
J Allergy Clin Immunol. 1991 Feb;87(2):540-8. doi: 10.1016/0091-6749(91)90013-e.
Inflammatory mediators have been implicated in the pathogenesis of human asthma and have been demonstrated to increase in bronchoalveolar lavage fluid during the time of the immediate asthmatic response (IAR) after allergen instillation in the lungs. However, the relationship of these mediators, measured early to the late asthmatic response (LAR), airway reactivity, and clinical asthma, is unknown. In the present study, we evaluated mediator levels in bronchoalveolar lavage fluid before and 5 minutes after allergen challenge from three subject groups: atopic subjects without asthma (N = 7), atopic subjects with asthma and without LAR [-) LAR) (N = 6), and atopic subjects with asthma and with LAR [+) LAR) (N = 6). Subjects with asthma were differentiated into subjects with and without LARs based on at least a 15% decrease in FEV1 between 3 to 8 hours postallergen inhalation. The mediators, prostaglandin D2 thromboxane B2 leukotriene C4 (LTC4), and histamine, were measured both before and after allergen instillation. Baseline prechallenge levels were similar, except in the case of LTC4. LTC4 was detectable at baseline significantly more frequently in the atopic subjects with asthma with and without LAR when these subjects were compared to the atopic subjects without asthma (nine of 12 detectable versus one of seven detectable). In all groups, significant increases in mediator levels were observed in the groups with asthma postallergen challenge, compared to the atopic subjects without asthma. Atopic subjects with asthma and without LAR had significantly higher levels of all four mediators after challenge than atopic subjects with asthma and with LAR and atopic subjects without asthma.(ABSTRACT TRUNCATED AT 250 WORDS)
炎症介质与人类哮喘的发病机制有关,并且已证实在肺部吸入变应原后即刻哮喘反应(IAR)期间,支气管肺泡灌洗液中的炎症介质会增加。然而,这些早期测量的介质与迟发性哮喘反应(LAR)、气道反应性和临床哮喘之间的关系尚不清楚。在本研究中,我们评估了三组受试者在变应原激发前和激发后5分钟支气管肺泡灌洗液中的介质水平:无哮喘的特应性受试者(N = 7)、无LAR的哮喘特应性受试者[-) LAR](N = 6)和有LAR的哮喘特应性受试者[+) LAR](N = 6)。根据变应原吸入后3至8小时内FEV1至少下降15%,将哮喘受试者分为有LAR和无LAR的受试者。在变应原注入前后均测量了前列腺素D2、血栓素B2、白三烯C4(LTC4)和组胺等介质。除LTC4外,激发前的基线水平相似。与无哮喘的特应性受试者相比,有LAR和无LAR的哮喘特应性受试者在基线时LTC4的可检测频率显著更高(12例中有9例可检测到,而7例中有1例可检测到)。与无哮喘的特应性受试者相比,所有哮喘组在变应原激发后介质水平均显著升高。无LAR的哮喘特应性受试者在激发后所有四种介质的水平均显著高于有LAR的哮喘特应性受试者和无哮喘的特应性受试者。(摘要截短于250字)